Adcendo, a developer of antibody-drug conjugates backed by TCGX, Orbimed and nearly a dozen other investors, raised a $135 ...

an innovative biotech company developing the next generation of gene therapies, today announced the successful completion of a Series A financing of $20 million. Proceeds from the financing will ...

Cradle raised $73 million in a Series-B investment round. With this, the biotech startup aims to invest heavily in its own AI ...

At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...

Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.

Enveda, a company using artificial intelligence to boost nature-based drug discovery, is envisioning clinical success with a ...

Adcendo is adding $135 million to its arsenal, money that will go toward launching several antibody-drug conjugate (ADC) ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it's never quite as straightforward to ...

Converge Bio offers a series of improvements that can be done ... “This is probably the biggest opportunity in biotech in five decades.” Yet many, perhaps most, biotech companies don’t ...